Pharmaceutical Technology | Drug Development News & Views …
WEBPharmaceutical news and in-depth feature articles on the new drug discoveries, healthcare research and development, big pharma trends and company deals.
Keytruda and Opdivo: a decade review - Pharmaceutical Technology
WEB22 hours ago · PD-1 inhibitors have revolutionised cancer treatment over the last decade, with their success attributed to Keytruda and Opdivo.
BMS and Prime ink potential $3.5bn deal to develop T cell therapies
WEB59 minutes ago · Under the terms of the deal announced yesterday (30 September), Massachusetts-based Prime Medicine will design gene editing reagents based on its proprietary PASSIGE technology with BMS taking these to develop ex vivo T cell therapies. Prime Medicine will receive a $55m upfront payment as well as $55m as an equity investment from BMS.
Artificial Intelligence in Pharma: Innovations, Patents, and Trends
WEBAug 20, 2024 · Pharma companies are increasingly leveraging artificial intelligence (AI) technologies to enhance their research and development processes, leading to innovative solutions in healthcare. Recent patents highlight advancements such as methods for identifying cancer treatment targets and optimizing drug combinations for colorectal carcinoma, which ...
Pharma developments in 2022: what you need to know
WEBJan 5, 2022 · A look at healthcare trends that will likely impact pharma's efforts to research and develop therapeutics in 2022. Against the backdrop of the Covid-19 pandemic, pharma and biotech companies continue to innovate not just in the field of therapeutics and vaccines, but also in terms of the science to develop them.
Sanofi/Regeneron’s Dupixent set to dominate COPD biologics …
WEB3 days ago · The US Food and Drug Administration (FDA) has announced the approval of Sanofi and Regeneron’s interleukin (IL)-4 and IL-13 monoclonal antibody, Dupixent, for the US market.
Pharmaceutical Technology’s most-read stories of 2023
WEBDec 19, 2023 · Our most popular stories of the year involve CRISPR therapies, generative AI, obesity drugs entering prime time, and changes in the Covid-19 landscape, signaling the biggest trends in the pharmaceutical and biotech industry.
FDA approves PureTech’s KarXT to treat schizophrenia in adults
WEB1 day ago · PureTech Health has obtained approval from the US Food and Drug Administration (FDA) for KarXT to treat schizophrenia in adults.
Pharma breakthroughs: 10 novel drug approvals that made …
WEBDec 20, 2023 · Pharma breakthroughs: 10 novel drug approvals that made headlines in 2023 Pharmaceutical Technology outlines some of the biggest US Food and Drug Administration (FDA) drug approvals announced in 2023 that are set to make an impact in the coming years.
How technology could transform drug research in 2022
WEBDec 14, 2021 · Pharmaceutical Technology takes a look at some of the tech innovations set to impact drug discovery and development in 2022. When we think of new technologies in medicine, we tend to conjure images of futuristic AI computers, 3D-printed organs, and robot surgeons. The ambitious and lesser-explored methods currently being applied in …